nodes	percent_of_prediction	percent_of_DWPC	metapath
Promethazine—DRD2—attention deficit hyperactivity disorder	0.409	0.564	CbGaD
Promethazine—HTR2A—attention deficit hyperactivity disorder	0.316	0.436	CbGaD
Promethazine—HTR2A—locus ceruleus—attention deficit hyperactivity disorder	0.00587	0.0864	CbGeAlD
Promethazine—CALM1—autonomic nervous system—attention deficit hyperactivity disorder	0.00512	0.0753	CbGeAlD
Promethazine—HTR2A—autonomic nervous system—attention deficit hyperactivity disorder	0.00312	0.0459	CbGeAlD
Promethazine—CHRM4—nervous system—attention deficit hyperactivity disorder	0.00152	0.0224	CbGeAlD
Promethazine—CHRM2—forebrain—attention deficit hyperactivity disorder	0.0015	0.0221	CbGeAlD
Promethazine—CHRM4—central nervous system—attention deficit hyperactivity disorder	0.00146	0.0215	CbGeAlD
Promethazine—CHRM1—forebrain—attention deficit hyperactivity disorder	0.00137	0.0201	CbGeAlD
Promethazine—CHRM2—cardiovascular system—attention deficit hyperactivity disorder	0.00127	0.0187	CbGeAlD
Promethazine—CHRM3—forebrain—attention deficit hyperactivity disorder	0.00122	0.018	CbGeAlD
Promethazine—CALM2—forebrain—attention deficit hyperactivity disorder	0.0012	0.0176	CbGeAlD
Promethazine—CALM1—forebrain—attention deficit hyperactivity disorder	0.00119	0.0176	CbGeAlD
Promethazine—CHRM5—nervous system—attention deficit hyperactivity disorder	0.00119	0.0175	CbGeAlD
Promethazine—CHRM4—brain—attention deficit hyperactivity disorder	0.00116	0.0171	CbGeAlD
Promethazine—CHRM1—cardiovascular system—attention deficit hyperactivity disorder	0.00116	0.017	CbGeAlD
Promethazine—CHRM5—central nervous system—attention deficit hyperactivity disorder	0.00114	0.0168	CbGeAlD
Promethazine—ADRA1A—forebrain—attention deficit hyperactivity disorder	0.00112	0.0165	CbGeAlD
Promethazine—DRD2—forebrain—attention deficit hyperactivity disorder	0.0011	0.0162	CbGeAlD
Promethazine—CALM2—cardiovascular system—attention deficit hyperactivity disorder	0.00101	0.0149	CbGeAlD
Promethazine—CALM1—cardiovascular system—attention deficit hyperactivity disorder	0.00101	0.0148	CbGeAlD
Promethazine—CALM3—midbrain—attention deficit hyperactivity disorder	0.00101	0.0148	CbGeAlD
Promethazine—ADRA1A—cardiovascular system—attention deficit hyperactivity disorder	0.00095	0.014	CbGeAlD
Promethazine—CHRM5—brain—attention deficit hyperactivity disorder	0.000908	0.0134	CbGeAlD
Promethazine—HRH1—forebrain—attention deficit hyperactivity disorder	0.00087	0.0128	CbGeAlD
Promethazine—CHRM2—nervous system—attention deficit hyperactivity disorder	0.000815	0.012	CbGeAlD
Promethazine—CALM2—midbrain—attention deficit hyperactivity disorder	0.000791	0.0116	CbGeAlD
Promethazine—CALM1—midbrain—attention deficit hyperactivity disorder	0.000787	0.0116	CbGeAlD
Promethazine—CHRM2—central nervous system—attention deficit hyperactivity disorder	0.000785	0.0116	CbGeAlD
Promethazine—CALM3—cerebellum—attention deficit hyperactivity disorder	0.000779	0.0115	CbGeAlD
Promethazine—CYP2B6—cardiovascular system—attention deficit hyperactivity disorder	0.000753	0.0111	CbGeAlD
Promethazine—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.000746	0.011	CbGeAlD
Promethazine—CHRM1—nervous system—attention deficit hyperactivity disorder	0.000742	0.0109	CbGeAlD
Promethazine—DRD2—midbrain—attention deficit hyperactivity disorder	0.000727	0.0107	CbGeAlD
Promethazine—HTR2A—forebrain—attention deficit hyperactivity disorder	0.000726	0.0107	CbGeAlD
Promethazine—CHRM1—central nervous system—attention deficit hyperactivity disorder	0.000715	0.0105	CbGeAlD
Promethazine—CHRM3—nervous system—attention deficit hyperactivity disorder	0.000664	0.00978	CbGeAlD
Promethazine—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.000662	0.00974	CbGeAlD
Promethazine—CALM2—nervous system—attention deficit hyperactivity disorder	0.00065	0.00957	CbGeAlD
Promethazine—CALM1—nervous system—attention deficit hyperactivity disorder	0.000647	0.00953	CbGeAlD
Promethazine—CHRM3—central nervous system—attention deficit hyperactivity disorder	0.000639	0.00942	CbGeAlD
Promethazine—CALM3—brain—attention deficit hyperactivity disorder	0.000633	0.00932	CbGeAlD
Promethazine—CALM2—central nervous system—attention deficit hyperactivity disorder	0.000626	0.00922	CbGeAlD
Promethazine—CHRM2—brain—attention deficit hyperactivity disorder	0.000623	0.00918	CbGeAlD
Promethazine—CALM1—central nervous system—attention deficit hyperactivity disorder	0.000623	0.00917	CbGeAlD
Promethazine—HTR2A—cardiovascular system—attention deficit hyperactivity disorder	0.000614	0.00904	CbGeAlD
Promethazine—CALM2—cerebellum—attention deficit hyperactivity disorder	0.000612	0.00901	CbGeAlD
Promethazine—ADRA1A—nervous system—attention deficit hyperactivity disorder	0.00061	0.00898	CbGeAlD
Promethazine—CALM1—cerebellum—attention deficit hyperactivity disorder	0.000609	0.00897	CbGeAlD
Promethazine—DRD2—nervous system—attention deficit hyperactivity disorder	0.000598	0.0088	CbGeAlD
Promethazine—ADRA1A—central nervous system—attention deficit hyperactivity disorder	0.000587	0.00864	CbGeAlD
Promethazine—DRD2—central nervous system—attention deficit hyperactivity disorder	0.000576	0.00847	CbGeAlD
Promethazine—ADRA1A—cerebellum—attention deficit hyperactivity disorder	0.000574	0.00845	CbGeAlD
Promethazine—CHRM1—brain—attention deficit hyperactivity disorder	0.000567	0.00835	CbGeAlD
Promethazine—DRD2—cerebellum—attention deficit hyperactivity disorder	0.000563	0.00828	CbGeAlD
Promethazine—CHRM3—brain—attention deficit hyperactivity disorder	0.000508	0.00747	CbGeAlD
Promethazine—CALM2—brain—attention deficit hyperactivity disorder	0.000497	0.00732	CbGeAlD
Promethazine—CALM1—brain—attention deficit hyperactivity disorder	0.000495	0.00728	CbGeAlD
Promethazine—CYP2B6—nervous system—attention deficit hyperactivity disorder	0.000483	0.00712	CbGeAlD
Promethazine—HTR2A—midbrain—attention deficit hyperactivity disorder	0.00048	0.00706	CbGeAlD
Promethazine—ABCB1—forebrain—attention deficit hyperactivity disorder	0.000476	0.00701	CbGeAlD
Promethazine—HRH1—nervous system—attention deficit hyperactivity disorder	0.000472	0.00695	CbGeAlD
Promethazine—ADRA1A—brain—attention deficit hyperactivity disorder	0.000466	0.00686	CbGeAlD
Promethazine—CYP2B6—central nervous system—attention deficit hyperactivity disorder	0.000465	0.00685	CbGeAlD
Promethazine—DRD2—brain—attention deficit hyperactivity disorder	0.000457	0.00673	CbGeAlD
Promethazine—HRH1—central nervous system—attention deficit hyperactivity disorder	0.000454	0.00669	CbGeAlD
Promethazine—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.000402	0.00593	CbGeAlD
Promethazine—HTR2A—nervous system—attention deficit hyperactivity disorder	0.000394	0.0058	CbGeAlD
Promethazine—HTR2A—central nervous system—attention deficit hyperactivity disorder	0.00038	0.00559	CbGeAlD
Promethazine—HTR2A—cerebellum—attention deficit hyperactivity disorder	0.000371	0.00546	CbGeAlD
Promethazine—CYP2B6—brain—attention deficit hyperactivity disorder	0.000369	0.00544	CbGeAlD
Promethazine—HRH1—brain—attention deficit hyperactivity disorder	0.000361	0.00531	CbGeAlD
Promethazine—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.000359	0.00529	CbGeAlD
Promethazine—Diltiazem—CACNA1C—attention deficit hyperactivity disorder	0.000353	0.0336	CrCbGaD
Promethazine—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.000346	0.00509	CbGeAlD
Promethazine—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.000338	0.00498	CbGeAlD
Promethazine—ABCB1—midbrain—attention deficit hyperactivity disorder	0.000314	0.00463	CbGeAlD
Promethazine—HTR2A—brain—attention deficit hyperactivity disorder	0.000301	0.00444	CbGeAlD
Promethazine—Methotrimeprazine—DRD5—attention deficit hyperactivity disorder	0.000287	0.0274	CrCbGaD
Promethazine—Propericiazine—DRD1—attention deficit hyperactivity disorder	0.000283	0.027	CrCbGaD
Promethazine—CYP2D6—brain—attention deficit hyperactivity disorder	0.000275	0.00404	CbGeAlD
Promethazine—Methotrimeprazine—ADRA2C—attention deficit hyperactivity disorder	0.000271	0.0258	CrCbGaD
Promethazine—Doxepin—ADRA2C—attention deficit hyperactivity disorder	0.000264	0.0252	CrCbGaD
Promethazine—Propericiazine—ADRA2A—attention deficit hyperactivity disorder	0.000263	0.0251	CrCbGaD
Promethazine—ABCB1—nervous system—attention deficit hyperactivity disorder	0.000258	0.0038	CbGeAlD
Promethazine—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.000249	0.00366	CbGeAlD
Promethazine—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.000243	0.00358	CbGeAlD
Promethazine—Chlorpromazine—DRD5—attention deficit hyperactivity disorder	0.000219	0.0209	CrCbGaD
Promethazine—ABCB1—brain—attention deficit hyperactivity disorder	0.000197	0.00291	CbGeAlD
Promethazine—Triflupromazine—DRD1—attention deficit hyperactivity disorder	0.000197	0.0187	CrCbGaD
Promethazine—Acepromazine—DRD1—attention deficit hyperactivity disorder	0.000182	0.0173	CrCbGaD
Promethazine—Thioproperazine—DRD1—attention deficit hyperactivity disorder	0.000178	0.0169	CrCbGaD
Promethazine—Mesoridazine—DRD3—attention deficit hyperactivity disorder	0.000176	0.0168	CrCbGaD
Promethazine—Pipotiazine—DRD1—attention deficit hyperactivity disorder	0.000175	0.0167	CrCbGaD
Promethazine—Propiomazine—DRD4—attention deficit hyperactivity disorder	0.000172	0.0164	CrCbGaD
Promethazine—Prochlorperazine—DRD3—attention deficit hyperactivity disorder	0.00017	0.0162	CrCbGaD
Promethazine—Cyamemazine—HTR2A—attention deficit hyperactivity disorder	0.000154	0.0147	CrCbGaD
Promethazine—Benzphetamine—SLC6A3—attention deficit hyperactivity disorder	0.000148	0.0141	CrCbGaD
Promethazine—Methotrimeprazine—DRD4—attention deficit hyperactivity disorder	0.000147	0.014	CrCbGaD
Promethazine—Propiomazine—DRD1—attention deficit hyperactivity disorder	0.000146	0.0139	CrCbGaD
Promethazine—Benzphetamine—ADRA2A—attention deficit hyperactivity disorder	0.000145	0.0138	CrCbGaD
Promethazine—Cyclobenzaprine—HTR2A—attention deficit hyperactivity disorder	0.000144	0.0137	CrCbGaD
Promethazine—Chlorprothixene—DRD3—attention deficit hyperactivity disorder	0.00014	0.0134	CrCbGaD
Promethazine—Triflupromazine—DRD2—attention deficit hyperactivity disorder	0.000139	0.0132	CrCbGaD
Promethazine—Chlorprothixene—DRD1—attention deficit hyperactivity disorder	0.000138	0.0131	CrCbGaD
Promethazine—Thioridazine—DRD1—attention deficit hyperactivity disorder	0.00013	0.0124	CrCbGaD
Promethazine—Clomipramine—ADRA2A—attention deficit hyperactivity disorder	0.000129	0.0122	CrCbGaD
Promethazine—Acepromazine—DRD2—attention deficit hyperactivity disorder	0.000128	0.0122	CrCbGaD
Promethazine—Promazine—DRD4—attention deficit hyperactivity disorder	0.000127	0.0121	CrCbGaD
Promethazine—Methotrimeprazine—DRD3—attention deficit hyperactivity disorder	0.000127	0.0121	CrCbGaD
Promethazine—Thioproperazine—DRD2—attention deficit hyperactivity disorder	0.000125	0.0119	CrCbGaD
Promethazine—Methotrimeprazine—DRD1—attention deficit hyperactivity disorder	0.000124	0.0119	CrCbGaD
Promethazine—Pipotiazine—DRD2—attention deficit hyperactivity disorder	0.000123	0.0118	CrCbGaD
Promethazine—Mesoridazine—DRD2—attention deficit hyperactivity disorder	0.000122	0.0116	CrCbGaD
Promethazine—Thioridazine—ADRA2A—attention deficit hyperactivity disorder	0.000121	0.0115	CrCbGaD
Promethazine—Trimipramine—SLC6A3—attention deficit hyperactivity disorder	0.000121	0.0115	CrCbGaD
Promethazine—Perphenazine—DRD1—attention deficit hyperactivity disorder	0.00012	0.0114	CrCbGaD
Promethazine—Trimipramine—ADRA2A—attention deficit hyperactivity disorder	0.000118	0.0113	CrCbGaD
Promethazine—Prochlorperazine—DRD2—attention deficit hyperactivity disorder	0.000118	0.0112	CrCbGaD
Promethazine—Methotrimeprazine—ADRA2A—attention deficit hyperactivity disorder	0.000116	0.011	CrCbGaD
Promethazine—Doxepin—ADRA2A—attention deficit hyperactivity disorder	0.000113	0.0107	CrCbGaD
Promethazine—Chlorpromazine—DRD4—attention deficit hyperactivity disorder	0.000112	0.0107	CrCbGaD
Promethazine—Perphenazine—ADRA2A—attention deficit hyperactivity disorder	0.000111	0.0106	CrCbGaD
Promethazine—Promazine—DRD1—attention deficit hyperactivity disorder	0.000108	0.0103	CrCbGaD
Promethazine—Desipramine—SLC6A3—attention deficit hyperactivity disorder	0.000106	0.0101	CrCbGaD
Promethazine—Propiomazine—DRD2—attention deficit hyperactivity disorder	0.000103	0.00977	CrCbGaD
Promethazine—Promazine—ADRA2A—attention deficit hyperactivity disorder	0.0001	0.00954	CrCbGaD
Promethazine—Acepromazine—HTR2A—attention deficit hyperactivity disorder	9.92e-05	0.00944	CrCbGaD
Promethazine—Amitriptyline—HTR1B—attention deficit hyperactivity disorder	9.85e-05	0.00938	CrCbGaD
Promethazine—Clomipramine—SLC6A4—attention deficit hyperactivity disorder	9.81e-05	0.00934	CrCbGaD
Promethazine—Chlorprothixene—DRD2—attention deficit hyperactivity disorder	9.71e-05	0.00925	CrCbGaD
Promethazine—Thioproperazine—HTR2A—attention deficit hyperactivity disorder	9.7e-05	0.00923	CrCbGaD
Promethazine—Chlorpromazine—DRD3—attention deficit hyperactivity disorder	9.67e-05	0.00921	CrCbGaD
Promethazine—Amitriptyline—DRD3—attention deficit hyperactivity disorder	9.56e-05	0.0091	CrCbGaD
Promethazine—Pipotiazine—HTR2A—attention deficit hyperactivity disorder	9.54e-05	0.00908	CrCbGaD
Promethazine—Chlorpromazine—DRD1—attention deficit hyperactivity disorder	9.49e-05	0.00904	CrCbGaD
Promethazine—Mesoridazine—HTR2A—attention deficit hyperactivity disorder	9.41e-05	0.00896	CrCbGaD
Promethazine—Thioridazine—DRD2—attention deficit hyperactivity disorder	9.19e-05	0.00875	CrCbGaD
Promethazine—Trimipramine—SLC6A4—attention deficit hyperactivity disorder	9.03e-05	0.00859	CrCbGaD
Promethazine—Trimipramine—DRD2—attention deficit hyperactivity disorder	8.98e-05	0.00855	CrCbGaD
Promethazine—Imipramine—SLC6A3—attention deficit hyperactivity disorder	8.95e-05	0.00852	CrCbGaD
Promethazine—Chlorpromazine—ADRA2A—attention deficit hyperactivity disorder	8.82e-05	0.0084	CrCbGaD
Promethazine—Methotrimeprazine—DRD2—attention deficit hyperactivity disorder	8.78e-05	0.00835	CrCbGaD
Promethazine—Amitriptyline—ADRA2A—attention deficit hyperactivity disorder	8.72e-05	0.0083	CrCbGaD
Promethazine—Doxepin—SLC6A4—attention deficit hyperactivity disorder	8.6e-05	0.00819	CrCbGaD
Promethazine—Doxepin—DRD2—attention deficit hyperactivity disorder	8.56e-05	0.00815	CrCbGaD
Promethazine—Trifluoperazine—DRD2—attention deficit hyperactivity disorder	8.53e-05	0.00812	CrCbGaD
Promethazine—Perphenazine—DRD2—attention deficit hyperactivity disorder	8.44e-05	0.00803	CrCbGaD
Promethazine—Propiomazine—HTR2A—attention deficit hyperactivity disorder	7.93e-05	0.00755	CrCbGaD
Promethazine—Desipramine—SLC6A4—attention deficit hyperactivity disorder	7.89e-05	0.00752	CrCbGaD
Promethazine—Desipramine—DRD2—attention deficit hyperactivity disorder	7.85e-05	0.00747	CrCbGaD
Promethazine—Promazine—DRD2—attention deficit hyperactivity disorder	7.6e-05	0.00724	CrCbGaD
Promethazine—Clomipramine—HTR2A—attention deficit hyperactivity disorder	7.54e-05	0.00718	CrCbGaD
Promethazine—Chlorprothixene—HTR2A—attention deficit hyperactivity disorder	7.51e-05	0.00715	CrCbGaD
Promethazine—Thioridazine—HTR2A—attention deficit hyperactivity disorder	7.1e-05	0.00676	CrCbGaD
Promethazine—Trimipramine—HTR2A—attention deficit hyperactivity disorder	6.94e-05	0.0066	CrCbGaD
Promethazine—Methotrimeprazine—HTR2A—attention deficit hyperactivity disorder	6.78e-05	0.00646	CrCbGaD
Promethazine—Imipramine—SLC6A4—attention deficit hyperactivity disorder	6.69e-05	0.00637	CrCbGaD
Promethazine—Chlorpromazine—DRD2—attention deficit hyperactivity disorder	6.69e-05	0.00637	CrCbGaD
Promethazine—Imipramine—DRD2—attention deficit hyperactivity disorder	6.66e-05	0.00634	CrCbGaD
Promethazine—Amitriptyline—SLC6A4—attention deficit hyperactivity disorder	6.65e-05	0.00633	CrCbGaD
Promethazine—Amitriptyline—DRD2—attention deficit hyperactivity disorder	6.62e-05	0.0063	CrCbGaD
Promethazine—Doxepin—HTR2A—attention deficit hyperactivity disorder	6.61e-05	0.00629	CrCbGaD
Promethazine—Trifluoperazine—HTR2A—attention deficit hyperactivity disorder	6.59e-05	0.00627	CrCbGaD
Promethazine—Perphenazine—HTR2A—attention deficit hyperactivity disorder	6.52e-05	0.00621	CrCbGaD
Promethazine—Desipramine—HTR2A—attention deficit hyperactivity disorder	6.07e-05	0.00578	CrCbGaD
Promethazine—Promazine—HTR2A—attention deficit hyperactivity disorder	5.88e-05	0.00559	CrCbGaD
Promethazine—Chlorpromazine—HTR2A—attention deficit hyperactivity disorder	5.17e-05	0.00492	CrCbGaD
Promethazine—Imipramine—HTR2A—attention deficit hyperactivity disorder	5.14e-05	0.0049	CrCbGaD
Promethazine—Amitriptyline—HTR2A—attention deficit hyperactivity disorder	5.11e-05	0.00487	CrCbGaD
Promethazine—CHRM3—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.46e-05	0.000126	CbGpPWpGaD
Promethazine—HTR2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.46e-05	0.000125	CbGpPWpGaD
Promethazine—HRH1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.45e-05	0.000125	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.44e-05	0.000125	CbGpPWpGaD
Promethazine—CHRM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.44e-05	0.000125	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	2.44e-05	0.000125	CbGpPWpGaD
Promethazine—CHRM3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.43e-05	0.000124	CbGpPWpGaD
Promethazine—CHRM5—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.43e-05	0.000124	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	2.42e-05	0.000124	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	2.42e-05	0.000124	CbGpPWpGaD
Promethazine—CALM2—RNF mutants show enhanced WNT signaling and proliferation—EP300—attention deficit hyperactivity disorder	2.42e-05	0.000124	CbGpPWpGaD
Promethazine—CALM1—RNF mutants show enhanced WNT signaling and proliferation—EP300—attention deficit hyperactivity disorder	2.42e-05	0.000124	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—DPYD—attention deficit hyperactivity disorder	2.42e-05	0.000123	CbGpPWpGaD
Promethazine—CHRM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.41e-05	0.000123	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	2.41e-05	0.000123	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	2.41e-05	0.000123	CbGpPWpGaD
Promethazine—ADRA1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.4e-05	0.000123	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	2.39e-05	0.000122	CbGpPWpGaD
Promethazine—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	2.37e-05	0.000121	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.37e-05	0.000121	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	2.36e-05	0.000121	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	2.36e-05	0.000121	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.34e-05	0.00012	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	2.33e-05	0.000119	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.33e-05	0.000119	CbGpPWpGaD
Promethazine—CALM3—Signaling by WNT in cancer—EP300—attention deficit hyperactivity disorder	2.32e-05	0.000119	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	2.32e-05	0.000118	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	2.32e-05	0.000118	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.3e-05	0.000117	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.27e-05	0.000116	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.26e-05	0.000115	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.25e-05	0.000115	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	2.25e-05	0.000115	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	2.25e-05	0.000115	CbGpPWpGaD
Promethazine—CALM2—Signaling by WNT in cancer—EP300—attention deficit hyperactivity disorder	2.25e-05	0.000115	CbGpPWpGaD
Promethazine—CALM1—Signaling by WNT in cancer—EP300—attention deficit hyperactivity disorder	2.25e-05	0.000115	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.25e-05	0.000115	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.23e-05	0.000114	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	2.22e-05	0.000113	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.2e-05	0.000112	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.19e-05	0.000112	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.18e-05	0.000111	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.18e-05	0.000111	CbGpPWpGaD
Promethazine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	2.18e-05	0.000111	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	2.14e-05	0.00011	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	2.14e-05	0.00011	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.14e-05	0.000109	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.13e-05	0.000109	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.12e-05	0.000108	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.12e-05	0.000108	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—TPH2—attention deficit hyperactivity disorder	2.11e-05	0.000108	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.11e-05	0.000108	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.11e-05	0.000108	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—DPYD—attention deficit hyperactivity disorder	2.08e-05	0.000106	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.07e-05	0.000106	CbGpPWpGaD
Promethazine—CALM3—Metabolism—TPH2—attention deficit hyperactivity disorder	2.06e-05	0.000105	CbGpPWpGaD
Promethazine—CALM3—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.06e-05	0.000105	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.05e-05	0.000105	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.04e-05	0.000104	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.04e-05	0.000104	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.03e-05	0.000104	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.03e-05	0.000104	CbGpPWpGaD
Promethazine—CALM3—Metabolism—DPYD—attention deficit hyperactivity disorder	2.02e-05	0.000103	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.02e-05	0.000103	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2e-05	0.000102	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2e-05	0.000102	CbGpPWpGaD
Promethazine—CALM2—Metabolism—TPH2—attention deficit hyperactivity disorder	1.99e-05	0.000102	CbGpPWpGaD
Promethazine—CALM2—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.99e-05	0.000102	CbGpPWpGaD
Promethazine—CALM1—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.99e-05	0.000102	CbGpPWpGaD
Promethazine—CALM1—Metabolism—TPH2—attention deficit hyperactivity disorder	1.99e-05	0.000102	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.97e-05	0.000101	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.97e-05	0.000101	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.96e-05	0.0001	CbGpPWpGaD
Promethazine—CALM3—Disease—SNAP25—attention deficit hyperactivity disorder	1.96e-05	0.0001	CbGpPWpGaD
Promethazine—CALM2—Metabolism—DPYD—attention deficit hyperactivity disorder	1.96e-05	0.0001	CbGpPWpGaD
Promethazine—CALM1—Metabolism—DPYD—attention deficit hyperactivity disorder	1.96e-05	0.0001	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.93e-05	9.88e-05	CbGpPWpGaD
Promethazine—DRD2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.92e-05	9.83e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling by Wnt—EP300—attention deficit hyperactivity disorder	1.92e-05	9.79e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—SNAP25—attention deficit hyperactivity disorder	1.9e-05	9.7e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—SNAP25—attention deficit hyperactivity disorder	1.9e-05	9.7e-05	CbGpPWpGaD
Promethazine—HRH1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.89e-05	9.66e-05	CbGpPWpGaD
Promethazine—CHRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.88e-05	9.62e-05	CbGpPWpGaD
Promethazine—CALM3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.88e-05	9.61e-05	CbGpPWpGaD
Promethazine—CHRM3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.88e-05	9.59e-05	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.87e-05	9.55e-05	CbGpPWpGaD
Promethazine—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.86e-05	9.5e-05	CbGpPWpGaD
Promethazine—ADRA1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.85e-05	9.48e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by Wnt—EP300—attention deficit hyperactivity disorder	1.85e-05	9.47e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by Wnt—EP300—attention deficit hyperactivity disorder	1.85e-05	9.47e-05	CbGpPWpGaD
Promethazine—CALM1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.82e-05	9.3e-05	CbGpPWpGaD
Promethazine—CALM2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.82e-05	9.3e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.81e-05	9.25e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.78e-05	9.1e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.78e-05	9.08e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.77e-05	9.05e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.77e-05	9.02e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.75e-05	8.94e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.75e-05	8.93e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.74e-05	8.91e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.72e-05	8.77e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.71e-05	8.74e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.71e-05	8.71e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.69e-05	8.64e-05	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.69e-05	8.63e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.69e-05	8.63e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.68e-05	8.6e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.68e-05	8.6e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.66e-05	8.46e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.65e-05	8.44e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.65e-05	8.42e-05	CbGpPWpGaD
Promethazine—CALM3—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.64e-05	8.4e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.64e-05	8.39e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.64e-05	8.36e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.64e-05	8.36e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.63e-05	8.33e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.63e-05	8.31e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.62e-05	8.29e-05	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.61e-05	8.22e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.6e-05	8.2e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.6e-05	8.19e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.6e-05	8.18e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.6e-05	8.15e-05	CbGpPWpGaD
Promethazine—CALM1—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.59e-05	8.13e-05	CbGpPWpGaD
Promethazine—CALM2—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.59e-05	8.13e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.59e-05	8.13e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.58e-05	8.09e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.58e-05	8.06e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.57e-05	8.05e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.57e-05	8.04e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.57e-05	8.02e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.57e-05	8.01e-05	CbGpPWpGaD
Promethazine—CALM3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.57e-05	8e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.56e-05	7.99e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.56e-05	7.96e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	1.56e-05	7.96e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.56e-05	7.96e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.55e-05	7.94e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.55e-05	7.91e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.55e-05	7.91e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.54e-05	7.89e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.54e-05	7.89e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	1.53e-05	7.83e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.53e-05	7.81e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.52e-05	7.79e-05	CbGpPWpGaD
Promethazine—CALM2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.51e-05	7.74e-05	CbGpPWpGaD
Promethazine—CALM1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.51e-05	7.74e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.5e-05	7.66e-05	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—COMT—attention deficit hyperactivity disorder	1.49e-05	7.6e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.48e-05	7.56e-05	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—MAOA—attention deficit hyperactivity disorder	1.48e-05	7.55e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	1.47e-05	7.5e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.47e-05	7.5e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	1.46e-05	7.44e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.46e-05	7.44e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.45e-05	7.41e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.45e-05	7.4e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	1.45e-05	7.38e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.44e-05	7.37e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.44e-05	7.35e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.44e-05	7.33e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	1.43e-05	7.32e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.43e-05	7.31e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.43e-05	7.31e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.43e-05	7.29e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.43e-05	7.28e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.42e-05	7.28e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.42e-05	7.26e-05	CbGpPWpGaD
Promethazine—HRH4—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.42e-05	7.23e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.38e-05	7.06e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.38e-05	7.06e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.37e-05	7.02e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.34e-05	6.86e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.33e-05	6.8e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.33e-05	6.8e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.33e-05	6.8e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.33e-05	6.8e-05	CbGpPWpGaD
Promethazine—CALM3—Hemostasis—EP300—attention deficit hyperactivity disorder	1.32e-05	6.73e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.31e-05	6.69e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.29e-05	6.6e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.29e-05	6.58e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.29e-05	6.58e-05	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—COMT—attention deficit hyperactivity disorder	1.28e-05	6.54e-05	CbGpPWpGaD
Promethazine—CALM2—Hemostasis—EP300—attention deficit hyperactivity disorder	1.27e-05	6.51e-05	CbGpPWpGaD
Promethazine—CALM1—Hemostasis—EP300—attention deficit hyperactivity disorder	1.27e-05	6.51e-05	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—MAOA—attention deficit hyperactivity disorder	1.27e-05	6.5e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.27e-05	6.47e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.27e-05	6.47e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.25e-05	6.39e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.25e-05	6.39e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.25e-05	6.37e-05	CbGpPWpGaD
Promethazine—CALM3—Metabolism—COMT—attention deficit hyperactivity disorder	1.25e-05	6.37e-05	CbGpPWpGaD
Promethazine—CALM3—Metabolism—MAOA—attention deficit hyperactivity disorder	1.24e-05	6.32e-05	CbGpPWpGaD
Promethazine—CALM2—Metabolism—COMT—attention deficit hyperactivity disorder	1.21e-05	6.16e-05	CbGpPWpGaD
Promethazine—CALM1—Metabolism—COMT—attention deficit hyperactivity disorder	1.21e-05	6.16e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.2e-05	6.15e-05	CbGpPWpGaD
Promethazine—CALM2—Metabolism—MAOA—attention deficit hyperactivity disorder	1.2e-05	6.12e-05	CbGpPWpGaD
Promethazine—CALM1—Metabolism—MAOA—attention deficit hyperactivity disorder	1.2e-05	6.12e-05	CbGpPWpGaD
Promethazine—CALM3—Innate Immune System—EP300—attention deficit hyperactivity disorder	1.19e-05	6.06e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.19e-05	6.06e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.17e-05	6e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.16e-05	5.95e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.16e-05	5.95e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.16e-05	5.95e-05	CbGpPWpGaD
Promethazine—CALM2—Innate Immune System—EP300—attention deficit hyperactivity disorder	1.15e-05	5.86e-05	CbGpPWpGaD
Promethazine—CALM1—Innate Immune System—EP300—attention deficit hyperactivity disorder	1.15e-05	5.86e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.12e-05	5.71e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.11e-05	5.66e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.03e-05	5.28e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.01e-05	5.18e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.01e-05	5.16e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.01e-05	5.15e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	9.98e-06	5.1e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	9.95e-06	5.08e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	9.44e-06	4.83e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	9.38e-06	4.79e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	8.9e-06	4.55e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	8.84e-06	4.51e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	8.82e-06	4.51e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	8.76e-06	4.48e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	8.5e-06	4.34e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	8.43e-06	4.31e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	8.16e-06	4.17e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	8.16e-06	4.17e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.94e-06	4.06e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.6e-06	3.89e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—EP300—attention deficit hyperactivity disorder	6.91e-06	3.53e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—EP300—attention deficit hyperactivity disorder	6.69e-06	3.42e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—EP300—attention deficit hyperactivity disorder	6.69e-06	3.42e-05	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—EP300—attention deficit hyperactivity disorder	6.38e-06	3.26e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—EP300—attention deficit hyperactivity disorder	6.38e-06	3.26e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—EP300—attention deficit hyperactivity disorder	6.17e-06	3.15e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—EP300—attention deficit hyperactivity disorder	6.17e-06	3.15e-05	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—EP300—attention deficit hyperactivity disorder	5.49e-06	2.81e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.47e-06	2.8e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.38e-06	2.75e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.37e-06	2.74e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.35e-06	2.74e-05	CbGpPWpGaD
Promethazine—CALM3—Metabolism—EP300—attention deficit hyperactivity disorder	5.34e-06	2.73e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.34e-06	2.73e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.29e-06	2.7e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.27e-06	2.69e-05	CbGpPWpGaD
Promethazine—CALM2—Metabolism—EP300—attention deficit hyperactivity disorder	5.17e-06	2.64e-05	CbGpPWpGaD
Promethazine—CALM1—Metabolism—EP300—attention deficit hyperactivity disorder	5.17e-06	2.64e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.47e-06	2.28e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.32e-06	2.21e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.32e-06	2.21e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	4.05e-06	2.07e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	3.82e-06	1.95e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	3.78e-06	1.93e-05	CbGpPWpGaD
